Resveratrol stereoselectively affected (±)warfarin pharmacokinetics and enhanced the anticoagulation effect

Resveratrol (RVT) has various beneficial bioactivities and popularly used as a dietary supplement. RVT showed inhibitions on CYP1A2/2C9/3A4, breast cancer resistance protein (BCRP), and some conjugated metabolites of RVT also inhibited BCRP. (±)Warfarin, an anticoagulant for cardiovascular disease but with narrow therapeutic window, were substrates of CYP1A2/3A4(R-form), 2C9(S-form) and BCRP. We hypothesized that the concurrent use of RVT might affect the metabolism and excretion of warfarin. This study investigated the effect of RVT on the pharmacokinetics and anticoagulation effect of (±)warfarin. Rats were orally given (±)warfarin (0.2 mg/kg) without and with RVT (100 mg/kg) in a parallel design. The results showed that RVT significantly increased the AUC0−t of S-warfarin and international normalized ratio. Mechanism studies showed that both RVT and its serum metabolites (RSM) inhibited BCRP-mediated efflux of R- and S-warfarin. Moreover, RSM activated CYP1A2/3A4, but inhibited CYP2C9. In conclusion, concomitant intake of RVT increased the systemic exposure of warfarin and enhanced the anticoagulation effect mainly via inhibitions on BCRP and CYP2C9.

• Publication year

  2020

• Venue

  Scientific Reports

• Publication date

  2020-09-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/s41598-020-72694-0PMID 32985569PMCID 7522226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trans-resveratrol, but not other natural stilbenes occurring in food, carries the risk of drug-food interaction via inhibition of cytochrome P450 enzymes or interaction with xenosensor receptors.

  2019cited by this paper
• Resveratrol attenuates the MSU crystal-induced inflammatory response through the inhibition of TAK1 activity.

  2019cited by this paper
• Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes.

  2018cited by this paper
• The effects of resveratrol supplementation on biomarkers of inflammation and oxidative stress among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.

  2018cited by this paper
• Resveratrol Protects SAMP8 Brain Under Metabolic Stress: Focus on Mitochondrial Function and Wnt Pathway

  2017cited by this paper
• R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies.

  2017cited by this paper
• Antioxidant effects of resveratrol in the cardiovascular system

  2017cited by this paper
• Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model

  2016cited by this paper
• Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity

  2014cited by this paper
• LDL cholesterol-lowering effects of grape extract used as a dietary supplement on healthy volunteers

  2013cited by this paper
• Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.

  2012cited by this paper
• The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters.

  2012cited by this paper
• Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Inductive modulation on P-glycoprotein and cytochrome 3A by resveratrol, a constituent of grapes

  2012cited by this paper
• Bioavailability of resveratrol

  2011cited by this paper
• Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis.

  2010cited by this paper
• Resveratrol bioavailability and toxicity in humans.

  2010cited by this paper
• A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2010cited by this paper
• Multidrug resistance proteins restrain the intestinal absorption of trans-resveratrol in rats.

  2010cited by this paper
• Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol.

  2009cited by this paper
• Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol

  2009cited by this paper
• The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane.

  2008cited by this paper
• Interaction of the breast cancer resistance protein with plant polyphenols.

  2004cited by this paper
• Warfarin and Other Coumarin Derivatives: Pharmacokinetics, Pharmacodynamics, and Drug Interactions

  2003cited by this paper
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers.

  1997cited by this paper
• Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions.

  1992cited by this paper
• The warfarin‐sulfinpyrazone interaction: stereochemical considerations

  1986cited by this paper
• The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats.

  1972cited by this paper

• Natural Non-carbohydrate Prebiotic Candidate: In Vitro and In Vivo Insights into Their Therapeutic Potential

  2026cites this paper
• Value of Diet and Nutraceuticals in the Prevention and Treatment of Mixed Alzheimer’s Disease and Vascular Dementia

  2026cites this paper
• A systematic review of the biological effects of resveratrol on venous thromboembolism

  2026cites this paper
• Potential Modulation of Polygoni Cuspidati Rhizoma et Radix on Breast Cancer Resistance Protein and Marked Alteration on Methotrexate Pharmacokinetics

  2025cites this paper
• Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology

  2025cites this paper
• Vaxtherapy, a Multiphase Therapeutic Protocol Approach for Longvax, the COVID-19 Vaccine-Induced Disease: Spike Persistence as the Core Culprit and Its Downstream Effects

  2025cites this paper
• Mechanistic Insights into Antioxidant Interventions Targeting Obesity-Induced Oxidative Stress in the Pathogenesis and Complications of Type 2 Diabetes Mellitus

  2025cites this paper
• A review on the role of polyphenols against periodontitis

  2025cites this paper
• Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine

  2024cites this paper
• Resveratrol as an adjuvant prebiotic therapy in the management of pulmonary thromboembolism.

  2024cites this paper
• Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies.

  2024cites this paper
• Mechanism of hypoxia-induced damage to the mechanical property in human erythrocytes—band 3 phosphorylation and sulfhydryl oxidation of membrane proteins

  2024cites this paper
• Sirtuin 1 and Hormonal Regulations in Aging

  2024cites this paper
• Scopoletin Improves Glucose Homeostasis in the High-Fructose High-Fat Diet–Induced Diabetes Model in Wistar Rats

  2023cites this paper
• Possible Side Effects of Polyphenols and Their Interactions with Medicines

  2023cites this paper
• Interactions of resveratrol and its metabolites (resveratrol-3-sulfate, resveratrol-3-glucuronide, and dihydroresveratrol) with serum albumin, cytochrome P450 enzymes, and OATP transporters.

  2022cites this paper
• Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine

  2022cites this paper
• Resveratrol Supplants Captopril’s Protective Effect on Cardiac Remodeling in a Hypertension Model Elicited by Renal Artery Stenosis

  2022cites this paper
• Simultaneous Characterization and Determination of Warfarin and Its Hydroxylation Metabolites in Rat Plasma by Chiral Liquid Chromatography-Tandem Mass Spectrometry

  2022cites this paper
• Bidirectional Influences of Cranberry on the Pharmacokinetics and Pharmacodynamics of Warfarin with Mechanism Elucidation

  2021cites this paper
• Comprehensive Investigation of Stereoselective Food Drug Interaction Potential of Resveratrol on Nine P450 and Six UGT Isoforms in Human Liver Microsomes

  2021cites this paper
• Analysis of inhibition kinetics of three beverage ingredients, bergamottin, dihydroxybergamottin and resveratrol, on CYP2C9 activity.

  2021cites this paper
• Food supplement vitamins, minerals, amino-acids, fatty acids, phenolic and alkaloid-based substances: An overview of their interaction with drugs

  2021cites this paper
• World Journal of Psychiatry

  year unknowncites this paper